Navigation Links
Virginia Woolf and Neuropsychiatry
Date:1/25/2013

Virginia Woolf and Neuropsychiatry, written by Maxwell Bennett, one of the leaders in the field of neurosciences, provides an explanation of the symptoms and untimely suicide of one of literature's greatest authors, Virginia Woolf. The sources used are letters and statements from Woolf herself, the literature she wrote and comments, letters and other documentation that refers to her mental state and her medical status. The author uses current insights into depression, the mental consequences of child abuse and drug interactions/effects to examine her life.

The second part of the book provides a neuropsychiatric analysis of the state of present knowledge concerning what goes awry in the functioning of the brain in depression, particularly leading to suicide. Five essays, aimed at specialists in neuropsychiatry, show how far we have probed brain functions related to major psychiatric problems.

Maxwell Bennett said: "Because of her literary genius, we find in her novels, plays, critical reviews, autobiographical sketches and diaries an unparalleled insight into the mind of someone destined to end their life. These offer those concerned with mitigating the incidence of suicide a unique opportunity to consider the circumstances and familial burdens that promote severe depression and so design programs that will ameliorate them."

M. R. Bennett AO is Professor of Neuroscience and University Chair at the University of Sydney, Founding Director of the Brain and Mind Research Institute and Adjunct Professor of Neuropsychiatry. He is the author of many papers and books in neuroscience and neuropsychiatry, including The Idea of Consciousness (1997) and a History of the Synapse (2001) as well as more recently Philosophical Foundations of Neuroscience (2003) and History of Cognitive Neuroscience (2008) with his colleague Peter Hacker. Maxwell Bennett is the recipient of numerous awards for his research in neuroscience.


'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert  

Page: 1

Related biology news :

1. Virginia Tech computer scientists develop new way to study molecular networks
2. TESARO and Virginia G. Piper Cancer Center announce first patient in clinical trial of TSR-011
3. Old deeds, witness trees offer glimpse of pre-settlement forest in West Virginia
4. Scientific meeting at Virginia Tech will make more than $2 million economic impact
5. Virginia Tech and University of Tuscia lead team to unravel origin of devastating kiwifruit bacterium
6. Biology professor secures grant to save West Virginias primary natural history collection
7. Virginia Tech announces 2012 football helmet ratings; 2 more added to the 5-star mark
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Virginia Woolf and Neuropsychiatry
(Date:12/8/2016)... 8, 2016  Singulex, Inc., the leader in Next ... into a license and supply agreement with Thermo Fisher ... provides Singulex access to Thermo Scientific BRAHMS PCT (Procalcitonin), ... is used to diagnose systemic bacterial infection and sepsis ... to aid in assessing the risk of critically ill ...
(Date:12/7/2016)... Dec. 7, 2016   Avanade is helping ... One teams in history, exploit biometric data in order ... and maintain the competitive edge against their rivals after ... Avanade has worked with Williams during the ... biometric data (heart rate, breathing rate, temperature and peak ...
(Date:12/6/2016)... Valencell , the leading innovator in ... a third consecutive year of triple digit growth for ... with a 360 percent increase in companies who have ... driven by sales of its wrist and ear Benchmark™ ... technology for hearables for fitness and healthcare applications. ...
Breaking Biology News(10 mins):
(Date:12/9/2016)... ... 2016 , ... Aditya Humad, Acting CFO of AxioMed and Managing Partner of ... States, Axiomed is now gaining interest from Silicon Valley. “It was satisfying to complete ... on to say that, “We expect interest to continue to rise as AxioMed completes ...
(Date:12/9/2016)... , Dec. 9, 2016 /PRNewswire/ - Portage Biotech Inc. ... PBT.U), is pleased to announce that Biohaven has issued ... New Haven, Connecticut (PRWEB) Dec 9, 2016 ... "Biohaven") announced today that the U.S. Food and Drug ... request covering its drug candidate BHV-0223, an orally dissolving ...
(Date:12/8/2016)... ... December 08, 2016 , ... Lajollacooks4u, San Diego’s premier team building events ... building events, new program offerings and company expansion. , This is largely ... include groups of over 30 people. Ever since, Lajollacooks4u has seen significant demand for ...
(Date:12/8/2016)... , Dec. 8, 2016  Biotheranostics today ... the role of the Breast Cancer Index (BCI) ... breast cancer are most at-risk for disease recurrence ... include results from three studies advancing the understanding ... related to tumor biology and inform decisions related ...
Breaking Biology Technology: